Up-regulation of the brain indoleamine 2,3-dioxygenase activity in a mouse model of Alzheimer's disease by systemic endotoxin challenge

International Congress Series

Volumn 1304, Issue , 2007, Pages 357-361

  Akimoto, Hidetoshi ^a   Yamada, Akiko ^a   Takikawa, Osamu ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Activated microglia; Alzheimer's disease; Indoleamine 2,3 dioxygenase; Inflammation; Lipopolysaccharide

Indexed keywords

EID: 35948985848     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2007.07.026     Document Type: Article

References (20)

1. Selkoe D.J. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann. N.Y. Acad. Sci. 924 (2000) 17-25
2. Streit W.J. Microglia and Alzheimer's disease pathogenesis. J. Neurosci. Res. 77 (2004) 1-8
3. Tony W.-C. Inflammation in Alzheimer disease: driving force, bystander or beneficial response. Nat. Med. 12 (2006) 1005-1015
4. Simard A.R., et al. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49 (2006) 489-502
5. Kim S.U., and de Vellis J. Microglia in health and disease. J. Neurosci. Res. 81 (2005) 302-313
6. Walker D.G., and Lue L.F. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases. J. Neurosci. Res. 81 (2005) 412-425
7. Stone T.W. Endogenous neurotoxins from tryptophan. Taxicon 39 (2001) 61-73
8. Schwarcz R., Whetsell Jr. W.O., and Mangano R.M. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219 (1983) 316-318
9. Kim J.P., and Choi D.W. Quinolinate neurotoxicity in cortical cell culture. Neuroscience 23 (1987) 423-432
10. Guillemin G.J., et al. Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus. Neuropathol. Appl. Neurobiol. 31 (2005) 395-404
11. Stone T.W., et al. The role of kynurenines in the production of neuronal death, and the neuroprotective effect of purines. J. Alzheimer's Dis. 3 (2001) 355-366
12. Widner B., et al. Degradation of tryptophan in neurodegenerative disorders. Adv. Exp. Med. Biol. 467 (1999) 133-138
13. Widner B., et al. Tryptophan degradation and immune activation in Alzheimer's disease. J. Neural Transm. 107 (2000) 343-353
14. Baran H., Jellinger K., and Deecke L. Kynurenine metabolism in Alzheimer's disease. J. Neural Transm. 106 (1999) 165-181
15. Mouradian M.M., et al. No changes in central quinolinic acid levels in Alzheimer's disease. Neurosci. Lett. 105 (1989) 233-238
16. Takikawa O., et al. Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase. J. Biol. Chem. 261 (1986) 3648-3653
17. Guillemin G.J., et al. Abeta1-42 induces production of quinolinic acid by human macrophages and microglia. NeuroReport 14 (2003) 2311-2315
18. Guillemin G.J., et al. Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia 49 (2004) 15-23
19. Sly L.M., et al. Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse mode of Alzheimer's disease. Brain Res. Bull. 56 (2001) 581-588
20. Cunningham C., et al. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 25 (2005) 9275-9284